The influence of 25-hydroxyl vitamin D3 deficiency on insulin resistance and bone mass in patients with type 2 diabetes

Shaoqing Li,Jian Wang
DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2015.06.006
2015-01-01
International Journal of Endocrinology and Metabolism
Abstract:Objective To explore the influence of 25-hydroxyl vitamin D3 deficiency on insulin resistance and bone mass in patients with type 2 diabetes.Methods A total of 386 patients with type 2 diabetes were divided into vitamin D deficiency group (195 cases)and normal group(191 cases) according to the plasma level of 25 (OH)D3.The cut point was 50 μg/L.Blood 25 (OH)D3, blood glucose related indicators, bone mineral density(BMD) and bone metabolism biochemical parameters were measured.Homeostasis model assessment-insulin resistance index (HOMA-IR), homeostasis model assessment-insulin secretion index (HOMA-B) and bone mass related indicators were compared between two groups.The correlation of 25 (OH)D3 with HOMA-IR and HOMA-B were analyzed.Results HOMA-IR in vitamin D deficiency group was higher than that of normal group, while HOMA-B was lower than that in normal group;the difference were statistically significant (t =2.78,9.43, all P < 0.05).BMD of lumbar spine in vitamin D deficiency group was lower than that in normal group, while the level of parathyroid hormone was higher than that in normal group;the difference were statistically significant (t =2.63,3.26, all P < 0.05).Calciumphosphorus product and alkaline phosphatase were not statistically different between two groups(all P > 0.05).25 (OH) D3 was negatively correlated with HOMA-IR (r =-0.592, P < 0.05), while was positively correlated with HOMA-B and BMD(r=0.662,0.553,all P<0.05) in vitamin D deficiency group.Conclusion The deficiency of blood 25 (OH) D3 in type 2 diabetes patients can lead to the deterioration of insulin resistance and the acceleration of bone mass loss.
What problem does this paper attempt to address?